BPH Treatment Industry Will Reach USD 18,837.7 Million by 2030

In 2021, the BPH treatment industry was worth around USD 11,892.8 million, and it is projected to advance at a 5.2% CAGR from 2021 to 2030, hitting USD 18,837.7 million by 2030, according to P&S Intelligence.

This growth can be credited to the growing favor for minimally invasive operations, the rising occurrence of BPH, and growing grants, investments, and funds for directing research on new treatments.

Get the sample pages of this report: https://bit.ly/3F8xBT1

Operation is an improved substitute to the management of BPH through medicine, but patients are leaning more towards the medicine because of the post-surgery harm to the body done by surgical burns and cuts. The growth of minimally invasive techniques has brought an alteration in patients’ perceptions and given medical device manufacturers a competitive advantage.

North America held the largest market share, of 41.0%, in 2021. The rising occurrence of the issue is boosting the acceptance of cutting-edge treatments, including prostatic stenting, laser therapy, and UroLift therapy, thus fuelling the market growth in the continent.

Additionally, the supportive reimbursement guidelines and an increasing number of skilled surgeons will aid the advance of the players in the continent in the coming few years.

The APAC region is projected to experience the fastest development in the coming few years, at a CAGR of 6.4%. The thriving disposable income and spending ability, rising living standards, growing urological illness burden, and increasing expenditure in the healthcare industry expand the progress.

Hence, growing favor for minimally invasive operations, rising occurrence of BPH, and growing grants, investments, and funds for directing research on new treatments are the major factors propelling the BPH treatment industry. 

Read More

North America Is Dominating the Facial Skin Ablative Treatment Industry

The global facial skin ablative treatment industry is experiencing growth and is projected to reach USD 8,394.3 million by 2030. according to a research report by a market research company P&S Intelligence.

This growth can be ascribed to the snowballing number of aesthetic methods being performed thought out the globe, advancements in technology, rising awareness regarding progressive aesthetic cures through conferences and seminars, increasing per-capita income and the thriving populace of aging people.

Get the sample pages of this report: https://bit.ly/3kx1Bk6

Based on technology, radiofrequency micro needling is projected to experience the highest growth in the coming years. This can be credited to the several advantages linked with it, including healthier outcomes without the requirement for boring processes, care, and very few side effects.

The acne and other scars category had the largest revenue share in the facial skin ablative treatment market, based on application, and is projected to continue to dominate in the future as well. This is mainly because of the high occurrence of acne in both women and men throughout the globe.

North America generated the largest revenue share in the market, in the past few years, and is projected to continue with the leading position in the future as well. This is mainly credited to the high occurrence of skin-related issues, such as acne and other kinds of marks, increasing knowledge associated with enhanced technologies, the solid existence of main market players in this continent, and growing concerns among people regarding their looks. 

For example, as per the American Academy of Dermatology, acne impacts approximately 50 million Americans every year.

The Asia-Pacific region is projected to develop at the uppermost growth rate in the market during the forecast period. This is because of the increasing healthcare investment and personal per-capita income, expanding aesthetic medical tourism industry, increasing population in the region, and snowballing expenditure by manufacturers.

For example, as per the World Bank, the healthcare investment by Japan was 9.1% of its gross domestic product in 2010, which increased to 10.9% of the GDP in 2018.

The elderly populace is playing a major role in the development of the facial skin ablative treatment market, as old age is linked with the damage of fibrous tissue, therefore leading to the incidence of dryness, skin sagging, wrinkles, and pigmentary alteration.

As per the United Nations Department of Economic and Social Affairs, the populace of individuals old 65 years and more will touch 225.4 million in India, 52.0 million in Brazil, 356.6 million in China, and 84.8 million in the U.S. by 2050.

Hence, snowballing number of aesthetic methods being performed thought out the globe, advancements in technology, and rising awareness regarding progressive aesthetic cures through conferences and seminars, are the major reasons contributing to the growth of the facial skin ablative treatment industry.

Read More

How Is Stringent Regulatory Environment Boosting Demand for ISOs' Medical Device Maintenance and Calibration Services in North America?

In North America, healthcare providers must regularly maintain their medical equipment due to the presence of a stringent regulatory framework. This is because medical equipment is used multiple times a day, which makes it prone to breaking down. For example, imaging systems, including endoscopes, ultrasound systems, and X-ray systems, are used in various clinical applications, and for enhancing their life and maintaining the accuracy of the results they provide, they require constant and proper maintenance.

Maintenance and calibration services also help in preventing the various infections caused due to the usage of unmaintained and unhygienic medical devices during surgeries and other procedures. Thus, the increasing emphasis on cleanliness in healthcare facilities will take the North American ISOs medical device and equipment maintenance and calibration services market from $1,468.8 million in 2019 to $3,612.9 million by 2030, at an 8.9% CAGR. Moreover, the World Health Organization has issued a few guidelines that focus on equipment maintenance, for controlling the spread of infections.

Get the sample pages of this report: https://bit.ly/3m2RjZo

In North America, the demand for these services is increasing at the highest rate for patient monitoring and electromedical devices. It is majorly attributed to the high prevalence of respiratory and cardiac diseases in the region, which lead to an extensive usage of this equipment. As per the CDC, “About 659,000 people in the United States die from heart disease each year—that's 1 in every 4 deaths.” In addition, the growing aging population and surging number of intensive care units (ICU) in the region are propelling the demand for such devices.

These and all other devices used in medical settings can be manual or automated, of which automated systems generate a higher demand for regular maintenance and calibration. It is ascribed to the government’s increasing financial support for healthcare automation. In addition, the continuous technological advancements in automation solutions and surging requirement for the reproducibility and accuracy of these devices are propelling their demand. Moreover, since automated devices are more complex than manual ones, healthcare providers choose to get them serviced by experts, rather than doing it in-house. 

This is also the reason that among portable, benchtop, and floor-based equipment, floor-based devices are serviced the most widely and frequently by ISOs. Floor-based systems have a larger size when compared to portable and benchtop ones and also various components that require to be regularly checked and repaired. This, in turn, means that hospitals have been approaching ISOs the most frequently among all kinds of healthcare spaces in the region. Moreover, the number of public hospitals, which are affordable for the masses, is rising in the region. 

Hence, with 951 community hospitals owned by local and state governments and 207 hospitals owned by the Federal Government, the U.S. will continue to be the larger market for medical device and equipment maintenance and calibration services by ISOs in North America over this decade. According to P&S Intelligence, it will also be due to the presence of established medical device manufacturers and ISOs in the U.S. and rising technological advancements in diagnostic tests. 

Therefore, the rising awareness about preventing infections by maintaining medical devices is propelling the demand for regular maintenance and calibration of medical equipment in North America, which is being increasingly met by ISOs, instead of OEMs and hospitals’ in-house staff.

Read More

Generic Drugs Giving Close Competition to Branded Drugs, But Why?

In today’s time, every other person is suffering from some or the other ailment. Some of them are related to the growing age, negligence of health and, if we talk about the worst-case scenario, then a person may be suffering from a chronic disease. If one is suffering from a disease, then it isa common phenomenon that he/ she will be administered some drug by the physician, to battle the or even control the condition.

The drugs that one takes may not always be branded, as it can sometimes be heavy on your pocket. As a solution of this issue, generic drugs can work well for a person, as it has the same salt as the blockbuster drugs, but to the advantage of your pocket, the patent has expired. 

In this blog, we will discuss about the facts about why these are becoming increasingly popular and why to switch toward them.

Just As Effective as Branded Drugs

If you are in doubt about the effectiveness of the generic medicines, put all the doubts to rest. The main element of any medicine is the salt used in the manufacturing of the same, and if the salt is same than it is a given that the effect will also be the same. 

Get the sample pages of this report: https://bit.ly/3KMdbTd

Easily Available at Nearby Stores

These medicines can come in really handy, when you don’t have time, or just don’t want to go far for the procurement of a medicine. These generic alternatives are generally available at the drug-store next door. Sometimes of the branded drug is not available in the vicinity you just have to open the internet, search for a generic alternative, and you will be sorted to say the least.

They Have the Approval of Councils

Some of you might think that generic drugs are not approved by the concerned regulatory authorities, but to your surprise they have got all the approvals just as their branded counterparts, and are also perfectly safe for consumption. The only thing the generic medicines lack is the patents, as their patents has expired, that’s why they are termed as generic drugs. So, next time, if anyone asks you about the safety concerns of these alternatives of branded drugs, surely say ‘go ahead’.

They are Fairly Economical

Money is perhaps the biggest factor that add to the prominence gathered by the generic drugs among the people. These drugs are generally in the reach of most people, unlike the medicines manufactured by the big names. Patent is an important thing for a medicine, but the main reason for which one takes a medicine, is to regain the health, and if one can get beck to the pink and that too by spending far less, it is definitely a win-win.

It is because of the various advantages associated with the generic drugs, the global demand will reach to a value of USD 705 billion by the year 2030, and who knows, the demand also might go way beyond this value.

Read More

What is Trending in Medical Cartridges Industry in Recent Times?

Drug delivery through cartridge-based systems is far from being a new technology in this contemporary world. The dental and insulin applications will also continue to be like this in the times to come. However, there is a growing trend toward other classes of drugs, including those used for treating auto-immune diseases, that never made the use of a cartridge, much before today.

As pharma companies evaluate the apt delivery system for their drug product, there are numerous reasons why they select a cartridge-based system, keeping aside the option of a pre-filled syringe. 

There are other benefits of these medical cartridges, to top the safe and accurate dosing, along with being fairly advantageous in the dosing flexibility and administer manifold doses in one container. Integration of a device and cartridge system can support the pharma industry’s lasting strategies and help in the differentiation of products.

Get the sample pages of this report: https://bit.ly/3KEzoCy

For pharma manufacturers, new fill-finish technology lets for a flexible design to fit numerous container systems. Though, component processing is a risky thing for cartridge components just, as it is for vial or syringe components. Many domestic component processing lines make use of old procedures, insufficient validation support, and even obsolete equipment. The investments needed for meeting quality expectations can be expensive and create a source of regulatory scrutiny in manufacturing.

Older procedures and equipment, cost money for maintaining or upgrading may cause variability in the quality of components. The risks related with in-house washing, sterilization and siliconization can be reduced by contracting out component processing.

For helping in decreasing the development time, drug development, and keeping manufacturing on-track, pharma manufacturers are trending toward ready-to-use components and containers. This flexible fill-finish tech is driving cartridge manufacturers to offer solutions in ready-to-use formats.

The various progressions in component processing helps to reduce the risk of variability in the quality of the component and the possible effects on drug product safety and effectiveness. cartridge components include less than 3mL cartridge plungers.

Advanced cartridge plungers are also being developed for meeting the need for ready to use sterile components for numerous uses characteristically administered with the use of a device, for example a pen injector. Cartridge plungers ARE designed to care for the needs of specified in standards for both glass cartridges and pen systems. 

The requirement for cartridges has increased, as a result of the increasing use in diagnostic applications, including magnetic resonance imaging tests and computed tomography scans . With an increase in the in cases of chronic diseases, for example cancer, volume of these type of diagnostic tests has increased all over the world.

All these above -mentioned trends in the medical cartridge industry have played a vital role in boosting the demand for medical cartridges globally, at a rapid pace. Thanks to all these developments, the total value of the industry will reach USD 1,691.1 million by the year 2030.

Read More

Why Does Pharmacies Category Dominate Lip Cold Sore Treatment Industry?

In China, South Korea, Taiwan, Hong Kong, and other SEA nations, the sale of lip cold sore treatment products is being driven by the rising incidence of herpes simplex virus 1 (HSV-1) infection and an increase in the modes of its transmission, as well as an increase in technological advancements, product launch, and research funding.

Due to this, it is anticipated that the lip cold sore treatment industry in South Korea, China, Hong Kong, Taiwan, and SEA will reach $85,265.1 thousand by 2030.

Get the sample pages of this report: https://bit.ly/3XYKHsg

Small blisters, known as cold sores, can appear on the lips or in the mouth. Certain types of the virus herpes simplex are responsible for causing cold sores (HSV). Cold sores are often caused by HSV-1. Typically, HSV-2 is to blame for genital herpes. To increase access to treatment patches, a lot of businesses are putting a lot of effort into making and selling them online.

Consequently, oral herpes, an infection within or around the mouth, is brought on. Additionally, both asymptomatic and asymptomatic viral shed is quite prevalent, which has made it possible for the virus to spread quickly to new people.

Based on the kind of product, the market is divided into cream, gel, patches, and other categories. The cream category had the highest proportion of these, and it is anticipated that it will continue to take the lead in the upcoming years. This is mostly a result of patients' growing preference for creams, which have a high rate of wound healing and virus eradication.

Based on the end user, the lip cold sore treatment market is divided into hospitals, clinics, and home care settings. Based on end-user, Clinics are anticipated to be the lip cold sore treatment market segment that would increase at the quickest rate over the projected period. This is mostly explained by the rise in patients visiting clinics with cold sores on their lips.

Based on the distribution channel, the pharmacies category held the biggest market share for lip cold sore therapy goods. Furthermore, given that patients with HSV-1 infection are typically given anti-cold sore treatment goods by a doctor, the category is anticipated to maintain its position in the next years.

China contributed the most to the industry in terms of geography in 2020. The nation is predicted to see the fastest growth throughout the predicted period. This is mostly due to the expanding frequency of HSV-1 infection amongst rural residents of the nation, the existence of significant industry actors, and growing public awareness of the illness.

The World Health Organization estimates that as of 2020, about 3.7 million people nationwide had HSV 1 infection. HSV-1 is spread by direct contact with diseased skin or saliva. Children who have a primary infection may experience a fever, burning gums, a painful throat, and swollen or inflamed neck glands.

In nerve roots near the afflicted epidermis, the virus then goes dormant. Rarely, if ever, does the virus reactivate in some people. Cold sores can develop as a result of secondary herpes episodes, which are recurrences of the virus in certain persons.

While the precise cause of reactivation is yet unknown, a number of things, including stress, dental work, sickness, lip damage, or sun damage, might cause an epidemic.

Read More

Why does the Pharmaceutical Sector Need RTU/RTF Vails?

Vials marked as ready-to-fill (RTF) or ready-to-use (RTU) are provided in a state that allows for quick filling without additional processing. For this, the vials must be thoroughly cleaned to get rid of dirt and chemicals, depyrogenated to get rid of endotoxins, and then terminally sterilized. Frequently, the vials come with the proper caps and stoppers to shut the bottles after filling. Glass RTU/RTF vials come in a wide variety of sizes and characteristics.

Increased demand for injectable medications, rising healthcare costs, expanding pharmaceutical sector, and the need for pharmaceutical businesses to boost operational efficiency are driving the growth of the worldwide RTF/RTU vials market.

Get the sample pages of this report: https://bit.ly/3KA8I5T

Manufacture of Ready-to-Use (RTU) Glass Vials

The initial production of ready-to-use glass vials is the same as that of regular glass vials. After production, the vials undergo different treatments or are sent to a different facility for additional care.

Washing. Normally, this procedure is carried out with an automatic washer. Vials will be sprayed with pressured, heated, high-quality water by the washer both within and outside.

Depyrogenation. The goal of this procedure, which is carried out in a hot oven, is to purge the vials of endotoxins. In a typical cycle, the vials are heated for around 30 minutes at 250°C.

Sterilization towards the end. The vials are packed in a sterile barrier before being sterilized with moist heat or ethylene oxide in this procedure.

More Information Related to RTU Glass Vials

1. The vials must be safeguarded against microbiological contamination during the depyrogenation procedure and before the filling procedure because there is no terminal sterilizing before filling. The degree of sterility guaranteed of 106 reached with terminal sterilization cannot be matched by an inline method, not even with the finest precautions.

2. Investing much in infrastructure and equipment is necessary for an inline process. For businesses that fill a few vials, this might not be feasible.

3. Endotoxins and sub-visible particles must pass a number of batch tests during the manufacturing of vials before filling. These tests are finished before filling ready-to-use vials. A test failure with inline systems may result in the rejection of the entire batch.

Why Usage of Injectable Drugs Is Increasing

In the upcoming years, the market for injectable medication delivery is expected to grow rapidly as a consequence of the increase in diabetes and cancer cases. For autoimmune illnesses, oncological disorders, hormonal abnormalities, orphan diseases, and a variety of other conditions, drugs are injected into the body.

Patients who are unable to take medications orally, nasally, or through other methods that involve motor functions—such as if they are unconscious or comatose—benefit from injectables. Due to the fact that RTF/RTU vials are mostly used for injectable medications, the increasing demand for injectable pharmaceuticals is driving up the need for vials.

Pharmaceutical Companies Must Improve Their Operational Effectiveness

Pharmaceutical companies are putting their efforts into simplifying their business processes and focusing on their core strengths, such as manufacturing and processing. Due to the elimination of numerous procedures, including washing, dehydrogenating, and sterilizing the vials, they are now employing RTF/RTU vials.

These procedures reduce the overall operational effectiveness of a pharmaceutical company and are not core business practices. As a result, pharmaceutical companies now favor fill/finish technology and packaging that can ensure sterility without incurring high costs.

Read More

Future Demand for Wheelchairs: What Data Is Saying!

Wheelchairs are necessary for the movement of people with a wide range of impairments. It is used by people with disabilities, those who are incapable to walk due to injuries or certain conditions like cerebral palsy, as a means of transportation. There are two different types of wheelchairs: manual wheelchairs and powered wheelchairs.

Both interior and outdoor uses are possible for them. The wheelchairs industry is predicted to rise in the near future as a result of new discoveries and inventions such as the stair climbing wheelchair, sports wheelchair, and smart wheelchair.

Get the sample pages of this report: https://bit.ly/3ZbCRg4

Mobility problems are a problem for people with poliomyelitis, arthritis, stroke, spinal cord injuries, muscular dystrophy, cerebral palsy, and other medical conditions. The necessity for official support services and the burden of care has decreased thanks to wheelchairs.  

The need for wheelchairs will rise as a result of the ability to let wheelchair users become mobile and participate in social activities. Investments in mobile technologies increase user quality of life while lowering healthcare expenditures and economic vulnerabilities.

Additionally, using a wheelchair reduces the risk of accidents, slips, early deaths, and additional impairments, which motivates people with disabilities to use wheelchairs more frequently.

Self-esteem is an assessment of one's value, and having a stronger sense of worth contributes to better health outcomes in general, decreases depression, and improves overall well-being among users. Due to their increased efficacy and utility among users, technological breakthroughs and other mechanical innovations are boosting the need for wheelchairs.

Choosing a wheelchair that suits each person's specific demands is crucial. Medical illnesses that call for wheelchairs come in a broad variety of forms and appearances. The wheelchair that provides the best chances for comfort, freedom, and mobility will be the correct wheelchair, whether it is manual or electric, sitting or standing, reclining or tilting.

Approximately 20% of Americans have a handicap, according to the most current U.S. Census data. A physical handicap or another form of mobility limitation affects around 10% of the population. About 3 million Americans rely entirely on wheelchairs or electric wheelchairs. The largest minority in the U.S. is comprised of people with disabilities.

The handicapped community views itself as metaphorically invisible. When making crucial decisions, many individuals, even leaders of the government and company owners, fail to take them into account. Their capacity to participate in communities is hampered by the absence of care.

Globally, the count of geriatric patients has significantly increased in recent years. The UN estimates that there were 703 million individuals 65 and over in the world in 2019; this number is expected to rise to 997.4 million by 2030. In addition, the older population is experiencing a greater proportion of chronic diseases than other diseases, which causes an increase in disability and a consequent rise in the need for wheelchairs.

Read More

Why We Need Professional Acne Treatment?

Although all types of acne may occasionally be referred to as "breakouts," this isn't always the case. Not all forms of acne cause skin to spread. Although hormonal changes that occur throughout adolescence are typically linked to acne, adults can also get acne. 

The professional acne treatment industry is predicted to reach USD 13,124.5 million by 2030 due to the escalating count of research programs, surging cases of acne, and increasing disposable income in developing and developed nations. Acne is one of the most prevalent skin diseases in both children and adults, affecting over 17 million Americans.

Get the sample pages of this report: https://bit.ly/3XXQyOF

Increasing Acne Prevalence

Due to the significant prevalence of acne among adolescents and young adults, cosmetician and dermatologist consultations are very common. One of the most common dermatological conditions, acne vulgaris affects the majority of people worldwide at some time in their lives.

For instance, the AAD estimates that 50 million Americans have acne each year, while the Global Health Data Exchange (GHDX) reports that 2.3 million Italians, 1.8 million Spaniards, and 3.7 million Germans experienced acne in 2019.

Types of Acne

Noninflammatory Acne: In non-inflammatory acne, blackheads and whiteheads are present. Normally, they don't result in edema. Additionally, they react rather well to OTC medications.

Salicylic acid is frequently advertised as a treatment for acne in general, however, it typically only works on noninflammatory acne. It naturally removes dead skin cells that might cause blackheads and whiteheads by exfoliating the skin.

Inflammatory Acne: Inflammatory acne is characterized by red, puffy pimples. Bacteria can contribute to pore obstruction in addition to oil and dead skin cells, which are factors in inflammatory acne. Deep under the skin, microorganisms can contaminate it and result in an illness. This might lead to excruciating acne lesions that are difficult to remove.

Products with benzoyl peroxide might aid with bacterial removal from the skin and edema reduction. These can also get rid of excess sebum. In addition to benzoyl peroxide, your doctor could advise an oral or topical antibiotic to treat the inflammatory acne. 

Whom To Consult

A skin is a wonderful organ. It protects the other organs, maintains you warm and cool, acts as the body's initial line of defense against disease, and provides data about the internal health.

Dermatologists are knowledgeable doctors with a focus on skin surgery. They possess the skills and knowledge required to give the best care possible to the organ that cares after you.

A board-certified dermatologist's extensive training enables them to properly diagnose and treat over 3,000 conditions affecting the skin, hair, and nails as well as cosmetic problems.

Growing Use of Professional Treatments for Acne

People are actively engaging in a thorough skincare program to treat scars, acne, and other skin issues in an effort to improve their looks. Treatment options range from topical remedies to systemic medications to lasers, physical modalities, and photodynamic therapy. 

Clinicians often advise using combination therapy, such as those that combine a topical antibiotic and a retinoid, to permanently reduce the incidence of acne.

Browse more related reports:

Scar Treatment Market Trends, Development and Demand Forecast to 2030

Skincare Devices Market Growth, Development and Demand Forecast to 2030

Read More

Increasing Prevalence of Diabetes Driving Single-Use NPWT Devices Industry

From $770.2 million in 2020, the single-use NPWT therapy devices market revenue is predicted to surge with a CAGR of 8.1%, to reach $1,673.1 million by 2030. The primary factors driving the market are the increasing adoption of C-section surgeries and growing prevalence of diabetes. Diabetics frequently need dressing as they are prone to diabetic foot ulcers, which are now increasingly being treated with NPWT, instead of conventional wound care procedures.

Get the sample pages of this report: https://bit.ly/3kimKyn

Moreover, wounds in diabetic patients develop quickly and heal slowly. In 2020, according to the Centers for Disease Control and Prevention, more than 34.2 million people had diabetes in the U.S. The growing population of diabetic patients is rapidly driving the demand for wound management products, including single-use NPWT devices. Moreover, older people face changes in the skin with age, which increases the risk of skin damage and wounds. Thus, the increasing geriatric population is another major single-use NPWT devices market growth driver.

The demand for these devices will also rise in the coming years due to the increasing prevalence of burns. The World Health Organization reported approximately 180,000 deaths due to burns in 2018. They are leading causes of disability-adjusted life years (DALY), which is used for determining the burden of the overall disease as the number of years lost due to ill health, early death, or disabilities. Burns cause some of the nastiest wounds, which are mostly untreatable with conventional therapies, thereby resulting in lifelong scars.

In this regard, another major growth driver for the single-use NPWT devices market is the rising number of road accidents. As per the WHO, these incidents lead to 1.3 million deaths each year, mostly in developing countries. While many die of the impact of the crash on the body itself, others slowly bleed to death, due to the lack of immediate wound care. In this regard, NPWT speeds up wound healing by sucking the exudate from the wound, instead of pressing on it.

Within the application segment of the single-use NPWT devices market, surgical wounds held the largest share in 2020. It is attributed to the surging volume of people with surgical wounds, itself due to the rising volume of surgeries. With the increasing prevalence of chronic diseases, consciousness on appearance, and rising number of people with physical injuries pushing up the footfall at operation rooms, the demand for single-use NPWT systems for treating surgical wounds continues to surge.

Geographically, North America held the largest share in the market in 2020, and it is expected to maintain its dominance in the coming years. It will be because of the high healthcare spending and presence of a large number of medical device manufacturers in this region. The surging number of research and development studies in the area and increasing awareness on these devices also result in their high adoption in the region. Additionally, APAC will also witness growth in the single-use NPWT devices market, due to the booming geriatric population. 

Thus, it can be said that the demand for single-use NPWT devices will increase in the coming years due to the surging cases of burns and growing prevalence of diabetes globally.

Read More

Why Are Sleep Disorder Patients Opting for Sleep Tech Devices?

The Sleep Charity estimates that insomnia affects around one in three persons in the U.K. Further, the Royal Australasian College of Physicians (RACP) states that around 33–45% of Australian adults experience inadequate sleep. Additionally, the American Sleep Association (ASA) reveals that approximately 30% of the adults suffer from insomnia in the U.S. The ASA also states that 25 million adults in the U.S. have obstructive sleep apnea. All these sleep disorders affect the mental health, body weight, work performance, thinking ability, and relationships of affected people and also lead to the development of diabetes and heart diseases.

Thus, the increasing prevalence of sleep disorders, such as insomnia, sleep apnea, restless legs syndrome, and parasomnias, is expected to drive the sleep tech devices market at a healthy CAGR of 14.5% during 2020–2030. The market was valued at $12,888.4 million in 2020 and it is projected to generate $49,984.7 million revenue by 2030. The market growth can also be attributed to the surging public awareness about the detrimental impacts of untreated sleep apnea. 

Sleep tech devices used to monitor sleep patterns of patients having insomnia, narcolepsy, sleep apnea, rapid eye movement (REM) sleep behavior disorder, and restless legs syndrome, are available in wearable and non-wearable forms. In the recent past, wearable devices were preferred over non-wearable variants, due to their portable nature and cost-effectiveness. Wearable devices are equipped with advanced microsensors that constantly monitor the physiological activities of an individual. Additionally, the ability of such devices to track-real time data makes them popular among people suffering from several sleep disorders.

The age segment of the sleep tech devices market is categorized into below 45 years, 45–64 years, and above 65 years. Under this segment, the below 45 years category is projected to demonstrate the fastest growth throughout the forecast period (2021–2030). This will be because of the extensive technical knowledge possessed by the people of this age group. In comparison to people of other age groups, individuals below 45 years can rapidly pick up new technology and master it. 

According to P&S Intelligence, North America will adopt the highest quantity of sleep tech devices in the foreseeable future. This will be on account of the high prevalence of chronic sleep disorders, the presence of a large number of obese people, the rise in the geriatric population, and the fast-paced lifestyle of people in the region. For instance, the Centers for Disease Control and Prevention (CDC) estimates that nearly 42.5% of adults aged 20 years and above in the U.S. were obese during 2017–2018. 

Whereas, the Asia-Pacific sleep tech devices market is expected to exhibit the fastest growth during the forecast period, owing to the increasing technological advancements, surging use of sleep technology, and booming geriatric population in the region. The United Nations Population Fund (UNFPA) states that the nearly 1.3 billion people in the APAC region will be over 60 years of age by 2050. As per the UNFPA, one in four people in APAC will be over 60 years old by 2050. 

Therefore, the surging incidence of sleep disorders and mounting public awareness about the ill effects of sleep apnea will create a huge requirement for sleep tech devices globally.

Browse more related reports:

Sleep Apnea Devices Market Growth, Development and Demand Forecast Report 2030

Sleeping Aids Market Growth, Development and Demand Forecast Report 2030

Read More

How Does Coronary Heart Disease Fuel Consumption of Interventional Vascular Consumables?

The worldwide interventional vascular consumables industry has garnered $3,929.2 million revenue in 2021, and it is projected to generate $5,501.7 million revenue in 2030, rising at a rate of 3.8% from 2021 to 2030.

The worldwide rising prevalence of cardiovascular disease boosts the requirement for interventional vascular procedures. For instance, around 17.9 million people succumb to death each year, which represents 32% of global deaths.

To learn more about this report: https://bit.ly/3xQ4xLD

Moreover, the increasing geriatric population fuels the demand for minimally invasive procedures, as they cause less risk, are less painful, and economical, and have a faster recovery compared to open surgeries. It further fuels the demand for consumables, including guidewires, catheters, and embolic protection systems.

The rise in the number of players in the industry fuels the consumption of cardiovascular devices and consumables.

Integer Holdings Corporation announced it set up facilities in Galway, Ireland in September 2021. It is expected to cater to the rising demand for regional research, development, and manufacturing, more specifically for catheters and delivery systems.

Confluent Medical Technologies announced to extend of its agreement for partnership with Allegheny Technologies Incorporated for manufacturing and supplying of ELI Nitinol, it is a specialized metal alloy utilized for producing high-performance minimally invasive medical devices and other components in January 2021.

Coronary interventional procedures hold 80% of the revenue share of the industry. The surging cases of coronary heart disease, associated with the rising elderly population fuels the demand for consumables during coronary procedures.

According to the CDC, coronary heart disease succumbed 360,900 people to die. In addition, the elderly population prefers minimally invasive procedures that include open surgeries which propel the demand for coronary consumables.

Catheters are projected to experience progress, accounting for 4% in the coming years. It is ascribed to higher catheters prices in comparison to other consumables, including more frequent usage, and presence of several types of catheters in the industry.

Furthermore, the presence of established players participating in product launches propels the industry. In July 2021, Medtronic plc introduced a new drug-coated balloon catheter for coronary artery disease treatment in Europe. The drug-coated balloon is utilized for percutaneous coronary intervention procedures for the treatment of patients with blocked or narrowed coronary arteries.

North America holds the largest industry share, accounting for 35.2% of the interventional vascular consumables industry. The continent leads the worldwide industry, due to surging healthcare expenditure, growing incidence of chronic diseases, and rising elderly population.

According to the Rural Health Information Hub report, in the U.S., 46 million people were aged over 65 years and more in 2020, and the number is projected to rise to almost 90 million in 2050. The rising elderly population results in a growing incidence of chronic diseases, which results in a surging demand for interventional vascular consumables.

Elderly people prefer interventional procedures, as these procedures possess a lower risk of complications and are highly affordable.

Furthermore, the surging healthcare expenditure in the North American region plays a great role, and it results in high accessibility of healthcare by the masses.

Therefore, the rising elderly population propels the demand for interventional vascular consumables.

Read More

Why Will North America Continue To Rule Operating Room Integration Market?

The major factors driving the global operating room integration market are the skyrocketing investment for improving the operating room infrastructure, swift adoption of technologically advanced devices, and rising congestion in ORs. In 2021, the revenue of the global market stood at $1,345.9 million, and it is predicted to touch $3,464.7 million by 2030, witnessing an 11.1% CAGR. Moreover, there is an inclination of patients toward minimally invasive surgeries (MIS) on account of their economic aspect, minute incisions, shorter duration, and quick recovery.

To learn more about this report: https://bit.ly/416RZgu

The integration of artificial intelligence and digital technology will spur the operating room integration market growth. For example, an ecosystem of interconnected ORs is being evolved by Proximie. This offers assistance to clinicians by using AI for incisions, as well as allowing for real-time analysis, data, and diagnostics. Furthermore, this platform assists healthcare experts not only in developing technical expertise, proctoring, and surgical mentoring but also in communicating with any connected OR globally. However, the outbreak of COVID-19 had decreased the investments in ORs globally.

Within the component segment, the market can be bifurcated into services and software. In 2021, the latter category held the bigger share in the market. This can be attributed to the benefits of operating room integration software, including better patient safety, enhanced communication among healthcare providers,  and up-to-date surgical workflow, as it is an all-in-one necessary information source. Therefore, healthcare corporations are gradually spending on OR integration. For instance, the management stakeholders in BNV and Marubeni invested in OPExPARK, to digitally transform ORs and offer a surgical training platform.

Documentation management systems are rather popular in various ambulatory surgical centers and healthcare centers, which is why this system type category accounts for approximately 40% global operating room integration market share. This can be ascribed to the rising incidence of diseases and, consequently, the surging patient population, which, in turn, increases the size and count of medical records. For example, an approximately 5% increase was observed in the total count of in-patients in 2021 over the previous year in Norway.

Within the application segment, general surgery will generate high revenue in the operating room integration market in the coming years. General surgeries are conducted on a bast array of body parts, including the endocrine system, soft tissue, skin, breast, abdomen, and its contents, as well as the esophagus and related organs. Moreover, the rising prevalence of liver cancer, endocrine disorders, and breast cancer will exert a push on the count of general surgeries performed globally. Thus, approximately one-third of the market share was held by the category in 2021. 

Geographically, North America held the dominating share in the operating room integration market in 2021, of at least 40%. This can be credited to the existence of prominent healthcare technology companies, surging requirement for quality care, and rising inclination toward MIS among patients. In addition, the APAC market will gain momentum in the forecast period at a 12% CAGR owing to the surging incidence of chronic diseases and, subsequently, the rising count of patients undergoing a surgery.

Hence, the snowballing population, coupled with the rising prevalence of chronic illnesses, will provide lucrative opportunities to the market players. 

Read More

What all Alterations have Occurred in Breast Reconstruction Treatment?

The process of breast reconstruction has drastically improved over the past 20-30 years. Apart from allowing safer procedures, these advances produce improved rates of recovery and aesthetics. They have aided patients of breast cancer and other survivors to experience regular and natural-looking fallouts that increase their confidence. Positive breast reconstruction trends comprise:

Improved Patient Awareness

Liberal legislative changes recently have prioritized the education of survivors of breast cancer survivors on rehabilitative options after a mastectomy. An instance is the Breast Cancer Patient Education Act, which necessitates all hospitals that achieve mastectomies to assume this accountability.

Breast cancer encouragement is another conscious effort that advances recovery rates. Activists campaign for safer screening approaches, more resources for breast cancer research, and healthier care for patients. For example, the earlier discovery of breast cancer upsurges the probability of successful treatment and breast reconstruction.

Get the sample pages of this report: https://bit.ly/3k3uMek

Enhanced Implant Placement Techniques

Breast reconstruction doesn’t use a one-size-fits-all method. Some patients retort better to tissue transfers artificial implants, or a blend of both. One of the state-of-the-art processes is less painful and endorses faster healing. Recognized as a pre-pectoral breast reconstruction procedure, it includes the insertion of the implants above your thoracic muscles.

This reconstruction method supports faster recovery since it does not influence your pectoral muscles. The MIS process permits your specialist to make a mastectomy and insert the transplant through a similar incision.

Enhanced Recovery Protocols

Progressions in anaesthesiology are contributing to more contented experiences for breast reconstruction patients. Surgeons prudently deliberate each step before, throughout, and after the process to safeguard the surgery resulting in a safe and fast recovery.

Numerous surgeons employ enhanced recovery after surgery protocols, which emphasize providing surgical care that supports an effectual recovery period. They comprise guidelines concerning the patient’s diet and managing pain medicine before the surgery.

Superior Tissue Reconstruction Techniques

Modern mastectomy procedures decrease the necessity for repeat surgeries. Cutting-edge natural tissue techniques permit surgeons to harvest extra skin and fat from your stomach area. They then transfer the tissue to your chest to reconstruct natural-look breasts.

This option is perfect if you can’t have a fake implant for medical and personal reasons. It can also have further cosmetic benefits. Along with restoring your breasts by means of normal and safe tissue, it results in a flatter tummy.

Substitutes to Nipple Reconstruction Surgery

Post-mastectomy, you might choose nipple reconstruction surgery after the process of breast reconstruction. Though, 3D tattoos can deliver the visual appeal of natural areolae deprived of additional surgery. They are so thorough that they can reconstruct the tiny bumps on the areola.

Knowledgeable artists are trying to produce exclusive textures. Apart from curing faster, these tattoos offer more options for advent, color, and size. Additional practices are as well as this service in their general breast reconstruction treatment.

It is all because of the new trends, the demand for breast reconstruction procedures is all on a high, and it will reach a value of about 1,019 million by the year 2030.

Read More

Technological Development Will Drive Electrophysiology Industry

The incidence of cardiac arrhythmias has become so high that new technologies must be included in the production of electrophysiological devices. The widespread use of minimally invasive electrophysiology therapy has been made possible by requiring highly precise and regulated cardiac diagnostic and ablation methods.

Additionally, interventionalists are now using disposable catheters for intermittent cardiac procedures since they are more sterile, safe, and affordable.

With the arrival of cutting-edge electrophysiological technologies, an increase in cardiac ablation treatments, and supportive payment policies, the need for electrophysiology is anticipated to grow steadily.

Thus, the global electrophysiology industry will reach $17,482.7 million by 2030. This can be attributed to technological developments, growth in the demand for diagnostic and ablation catheters, and increase in the prevalence of atrial fibrillation in older people.

A major cause of mortality, according to the World Health Organization (WHO), is cardiac problems, which are grave health issues. The therapy of cardiac arrhythmias involves using several interventional techniques and implanted cardiac devices.

Get the sample pages of this report: https://bit.ly/3S1XVmS

Highest Revenue Was Generated by Sale of Ablation Catheters

The category of ablation catheters now has the biggest share. With the help of catheters, damaged electrical circuits in the heart are eliminated during ablation, a minimally invasive procedure.

The device can be utilized to remove abnormal cardiac tissue that contributes to abnormal heart rhythms. The two ablation catheter methods that are most often employed are radiofrequency and cryoablation, and as technology progresses, their use is projected to increase significantly.

Technological Advances are driving Demand in Electrophysiology Devices

The burden of heart disorders has decreased due to changes in treatment methods for cardiac arrhythmias brought about by technological improvements.

The patient pool is expected to grow globally as the aging population surges. This is anticipated to fuel the electrophysiological ablation catheter market during the next few years. CVDs are the leading cause of mortality worldwide, according to the WHO.

About 32% of all fatalities worldwide occurred due to CVDs in the previous year, killing approximately 17.9 million individuals. An estimated 85% of these fatalities were attributed to heart attacks and strokes.

During the projected period, there is anticipated to be an increase in the need for electrophysiology ablation catheters due to the rise in the prevalence of cardiovascular illnesses in the geriatric population.

Cardiac and Hospitals Centers Has Largest Share

The biggest end customers of electrophysiology products are hospitals and cardiac facilities. As a result, the category now has the biggest share in the electrophysiology market.

Additionally, this is a result of an increase in the number of ablation operations performed in public and private hospitals worldwide and increased utilization of electrophysiology and Cath labs.

Hospital-based care is in great demand due to the availability of state-of-the-art facilities for disease diagnosis and treatment and competent employees. Compared to other medical facilities, hospitals do more screening and diagnostic procedures, which results in a significant share.

Additionally, due to the development of superior electrophysiological products and the demand for minimally invasive treatments, the use of electrophysiology devices in various healthcare settings is increasing.

Read More

Increasing Incidences of Cancer Boost Demand for Radioligand Therapy

Radioligand therapy involves the application of radioactive atoms to advanced cancers. It helps in delivering the radiation to the target cells in the body. This therapy aims at limiting the damage around the tissues. For over a decade, targeted radiation with radioisotopes has been used in the treatment of thyroid cancer.

Get the sample pages of this report: https://bit.ly/3K4WnXi

Presently, radioligand therapy is widely utilized in the field of oncology. Several such therapies have received approval for a number of cancer treatments, including metastatic castration-resistant prostate cancer, and midgut neuroendocrine tumours. It is also known as targeted radiotherapy, systemic radiation therapy, targeted radionuclide therapy, and peptide-receptor radionuclide therapy. 

The specialists in nuclear medicine will require fully integrated multidisciplinary cancer care teams, and precise resourcing to provide radioligand therapy in hospitals and nuclear waste facilities. These therapies have been effective in aiding the progression-free survival and quality of life for numerous patients.

The radioligand industry has garnered $7,785.6 million revenue in 2021, and it is projected to generate $13,073.9 million revenue in 2030, advancing at a rate of 5.9% in the coming future. The demand for radioligand therapy is rising with FDA-approved drugs showing low side effects. 

Healthcare systems widely utilise and integrate radioligand therapy. It provides life-enhancing treatment for cancer patients with limited therapeutic options. It involves the integration of nuclear medicine to ensure it is precisely embedded into cancer care.

The major companies operating in the industry are; Novartis International AG, Telix Pharmaceuticals, Molecular Partners, Bayer AG, ITM Isotope Technologies Munice SE, Radio Medix, Pfizer Inc., and Janssen Global Services LLC. 

Therefore, the rising prevalence of cancer propels the demand for radioligand therapy.

Read More

Why North America Held Largest Share in RNA Analysis Industry?

Research on RNA analysis spans a broad spectrum of issues, from an in-depth examination of the transcriptome—the whole collection of RNA transcripts transcribed by a genome—to examining the effects of individual short noncoding RNAs on particular genes.

The RNA analysis market is predicted to hit $14,909.8 million by 2030. The two main factors are the increasing use of RNA analysis to develop medications for illnesses that are difficult to cure or have no treatment, including cancer and uncommon genetic disorders, and the expanding demand for RNA sequencing as the primary approach for toxicogenomic research.

To learn more about this report: https://bit.ly/3RVUQEG

Next-generation sequencing is one of the most popular technologies for transcriptomics, and it is predicted that it will keep up its usage throughout this decade. The expansion of this category is attributed to the development of precision medicine and the rise in RNA sequencing research investigations due to its benefits over traditional methods.

The need for equipment like high-throughput sequencers has increased along with the development of new technologies due to the recent sharp increase in the demand for sequencing-based diagnostics. As a result, businesses are putting more emphasis on developing new products. CureVac N.V., for instance, founded CureVac RNA Printer GmbH as a subsidiary to enhance The RNA Printer.

One of the critical elements driving RNA analysis market in the medication research and development process is the emergence of RNA-based therapies. RNA-based medications are being investigated for diseases that are difficult to treat and for which there is presently no cure, including AIDS, cancer, and diabetes. Companies involved in this field are working together to produce RNA-based medications.

The share for RNA analysis in North America was about 40%, with the U.S. dominating the sector and Canada likely experiencing the fastest increase in the coming years.

This expansion is linked to supportive government programs for pharmaceutical research and development, rising healthcare spending, and expanding access to modern healthcare facilities. The result of other chronic diseases and the sheer volume of cancer patients also contribute to the surge.

Drug discovery and development methods for determining medication safety and efficacy have been expedited using biomarker detection in clinical applications. Additionally, biomarkers for cancer and neurological disorders are essential for understanding the development and mechanism of disease. There are several applications for the microarray technology used in transcriptome analysis to study hereditary diseases.

Through the transcriptome sequencing of RNAs extracted from PBMCs and BALF specimens of COVID-19 patients, clinical advice on anti-inflammatory medicines is being obtained, and the molecular underpinnings of the SARS-CoV-2 infection are being understood to develop effective therapies.

It is projected that the use of transcriptomics methods in discovery and drug discovery will increase due to the rising necessity to analyze a vast number of genes to comprehend the gene-to-drug interactions.

For instance, the therapy and prognosis of COVID-19 patients' transcriptome profiles have been examined. Furthermore, it is projected that throughout the forecast period, rising demand for tailored medications would fuel industry expansion.

Read More

Epigenetics Industry To Propel At a Mammoth Growth rate of over 17%

In 2021, the size of the epigenetics market was about $1,564 million, and it is will advance at a mammoth growth rate of over 17% in the years to come, to reach a value of around $6,461 million by 2030.  The factors affecting the growth of the industry include the fast development of simple, lucrative and advanced epigenetically kits and increasing acceptance of precision medicine all over the world.

The kits, assays, and reagents had over 60% share in the recent past. This is generally credited to the rapid expansion of simple, affordable, and innovative epigenetics kits and reagents. Also, there has been a surge in product launches, consciousness of non-oncological ailments and epigenetics, and prominence on the acceptance of precision medicine tactics recently.

To learn more about this report: https://bit.ly/3HYxBpd

Oncology made a significant amount of revenue in 2021 for the reason of the momentous increase in the number of cancer cases every year. This will increase as the worldwide occurrence of cancer and related fatalities increase. Also, the industry will grow due to the product launches and the likely commercialization of the products by now thought about for the future.

Pharmaceutical & biotechnology corporations had the largest demand. This is because of the research and development actions on microorganism-derived drug resistance, molecular aspects of cancer, oncology, and drug discovery for non-oncology purposes. Also, the growth would be powered by the growing research in genetics, with a strong prominence on modified treatment.

In 2021, North America had the highest revenue. The dominance is because of the existence of innovative healthcare infra and well-known companies following research and development in epigenetics, increasing count of cancer patients, and snowballing acceptance of products based on cutting-edge molecular know-hows by pharmacological and biotechnological corporations. Also, a great importance on epigenetics biomarker research like on DNA, histones, and non-coding RNA, will support the regional market growth.

Europe followed North America epigenetics market with over 25%, in the recent past because of the surge in the incidence of chronic diseases that require detailed diagnosis. More than a few European countries like France, Germany, the U.K., Spain, and Italy are working tirelessly for improving research initiatives. Further, because of the high backing, the European region has at all times been at the frontrunner of research and diagnostics globally.

APAC will witness the highest growth rate of over 15%, in the years to come. The growing healthcare consciousness, a stable economy leading to a firming emphasis on research, and extensive acceptance of NGS- and PCR-based diagnostic assays and kits will boost the industrial growth. Moreover, because of the high cancer incidence, pharmaceutical and biotechnology businesses are ensuring adequate healthcare amenities in the region.

The increasing incidence of cancer has a major role to play in the increasing demand for epigenetic processes.

Read More

How Does Medical Image Analysis Software Help in Providing Personalized Care?

The medical image analysis software industry has garnered $3,112.7 million revenue in 2021, and it is projected to generate $6,388.9 million revenue in 2030, advancing at a rate of 8.3% in the coming years. It is attributed to the surging population and increasing incidences of chronic diseases, with wide usage of computer-aided diagnosis.

To learn more about this report: https://bit.ly/3lyPqDs

In addition, the rising demand for diagnostic imaging in oncology, urology, orthopedics, neurology, and cardiology propels the industry's growth.

Healthcare technologies such as radiography, MRI, nuclear imaging, and ultrasonography are utilized for the diagnosis of chronic disorders or non-communicable diseases, as they produce pictures of the inside organs of the body. The surging requirement for modern software and enhanced imaging technologies is projected to boost industry growth.

North America leads the healthcare R&D, with a rising number of healthcare and diagnostic centers in the region. It captures the largest industry share, globally. In addition, the industry players are focusing on introducing new products that aid effective diagnosis and image-guided surgeries.

The U.S. has a higher demand for computer programs to facilitate better medical image analysis, led by the massive investments from private and government sectors, rising penetration of healthcare facilities, and increasing frequency of chronic diseases, including CVDs, and cancer.

Moreover, the European medical imaging analysis industry is projected to rise at a fast pace. It is ascribed to the rising adoption of telemedicine, increasing healthcare expenditure, technological advancements, rising awareness of the early diagnosis of diseases, and penetration of established players.

The major players operating in the industry are:

1- Siemens Healthineers

2- Canon Inc.

3- AQUILAB SAS

4- Xinapse Systems Ltd.

5- Agfa Gevaert N.V.

6- INFINITT Healthcare Co. Ltd.

7- Agfa Gevaert N.V.

Therefore, rising incidences of CVDs propel the demand for medical imaging analysis software for effective diagnosis.

Read More

How Does Cancer Drug Discovery Impact Microarray Analysis Industry?

The microarray analysis industry contributes revenue worth $3,846.7 million in 2021, and it is projected to rise at a rate of 9.9% in the coming future, to generate $9,011.1 million in revenue in 2030. 

It is ascribed to the rising application area of microarrays, growing cancer prevalence, and government initiatives for proteomic and genomic research. Microarray analysis is highly utilized in pharmaceutical screening, toxicology screening, and biomarker identification to understand DNA mutation. In addition, microarray facilitates the screening of various genes in real-time.

To learn more about this report: https://bit.ly/3lyrUH3

Moreover, North America holds a significant share of the microarray analysis industry, accounting for 40%, and it is projected to experience extensive growth in the near future, leading to increased funding from Canada and the U.S. governments for cancer research.

Under the project and category segment, consumables are expected to experience significant growth of around 10% from 2021 to 2030, led by the rising number of research institutes and diagnostic laboratories that use microarray analysis. In addition, the rising research on mRNA and DNA methylation boosts the demand for consumables to carry out microarray analyses.

In addition, software and services capture the third-largest share of the microarray analysis industry, attributed to the wide usage of the software for identifying and analyzing genomes by utilizing data for the study. Similarly, the rising number of experiments boosts the advanced services and tools adoption for carrying out studies.

DNA microarrays capture a substantial share of the industry, and it is projected to experience a growth rate of 10% in the coming years, owing to the DNA microarray's usage in clinical diagnostic tests for various diseases. Moreover, they are also utilized for determining which medicine is the best prescription for a specific patient, as these genes identify how the body manages the drug chemistry.

In addition, DNA microarrays are primarily used for mutation identification in the genetic structure. The short-single stranded DNAs of genetic disorders are produced and combined with patients' DNA for analysis. The synthetic binding of DNA with the produced DNA, and coherent material facilitates the identification of mutation type of cancer. Therefore, the growing prevalence of cancer is the primary contributor to the rising demand for DNA microarrays.

The research and academic institutes capture an extensive share of the microarray analysis industry, and they are projected to contribute to the sales worth $4.0 billion of the associate products in 2030. Over the years, there has been a significant rise in human genome study projects. Microarrays are utilized for cancer drug discovery. Therefore, the rise in research and development investments in the healthcare sector is projected to boost industry growth.

Moreover, the pharmaceutical and biotechnology companies are projected to experience rapid growth in the industry, ascribed to various research programs conducted for drug development.

In addition, Europe is the next-significant contributor after North America, attributed to the highly developed healthcare industry of the region, with advanced R&D infrastructure, and ease of access to the associated products. Cancer detection supported by point-of-care testing in Europe drives the industry growth.

Therefore, the rising investments in research and development in the healthcare sector are projected to boost industry growth. 

Read More

How Endoprosthesis can Help the People Suffering from Bone Cancers?

Limb Salvage Operation can now be advised for about 90% of the people who are detected with bone cancer. This is possible because of the initiation of modular endoprosthesis, development in surgical methods, diagnostic moods, improved chemotherapy medications and regimes and the better comprehension of bone malignancies.

These kinds of surgeries require scrupulous pre-operative planning and necessitates the orthopaedic surgeon to deliberate the case in a multi-disciplinary institution and cancer centre which has all the necessary supportive units. A trained and knowledgeable Musculo-Skeletal Radiotherapist, an expert team of Vascular surgeons, support of plastic surgery in addition to the Orthopaedic surgeon form the main team for carrying out these kinds of procedures.

Get the sample pages of this report: https://bit.ly/3IjQ2pB

Parts of Limb Salvage Surgeries

Salvage Surgeries of the limbs mostly comprise two parts, Resection and Reconstruction.  The former includes removal of the bone which has tumour safely out of the body by possessing a margin of usual tissue round the bone, in such a manner that there is no tumour left. Reconstruction includes replacement of the bone/ joint resected out by the help of metal prosthetic device or supplementary biological approaches.

The metal prostheses are better known as endoprostheses and are formulated with the help of special metals, alloys for example, stainless steel, cobalt-chromium or titanium.  These prostheses of metal are obtainable willingly, light-weight, modular yet tremendously strong.

In the meantime, one size doesn’t fit all the people, modular endoprostheses in various size and shape are available for altering as per the size of the joint and bone length resected out. Endoprostheses permit patients to tolerate weight on them when the lower limb reconstructions take place practically immediately after the surgical procedure. Patients can recommence the activities incorporated in the daily routine like, climbing stairs, walking and other routine activities subsequently two-three weeks post-surgery with the assistance of these modular endoprostheses.

At the present time, lower limb endoprostheses which include rotating platforms are obtainable for rebuilding in resection of tumours in the bone about the knee joint, where the knee joint requires to be replaced. Likewise, collars that are hydroxyapatite coated for endoprostheses stems are accessible allowing bone incorporation and overgrowth around the metal stem- bone edge.

All these fresh progressions in metallurgy and their novel designs have helped to increase the durability of these modular endoprostheses, in that way declining a number of difficulties which were earlier seen with these prosthetic devices.

It is because of the increasing cases of peripheral vascular diseases and orthopaedic illnesses and increasing knowledge of patients regarding the use of prostheses for orthopaedic injuries. Owing to all these reasons the demand for endoprosthesis will reach a value of around $65,998 million by 2030, at a growth rate of over 12% all across the globe.

Read More

How Does Growing Preference for Portable ECMO Machines Impact Extracorporeal Membrane Oxygenation Machines Industry?

In 2021, the extracorporeal membrane oxygenation machine industry contributes $529.4 million in revenue, and it is projected to reach $834.5 million in 2030, advancing at a rate of 5.2% in the coming future. It is ascribed to the growing prevalence of cardiopulmonary and respiratory diseases, and the rising number of people undergoing ECMO therapy caused by the growing incidences of chronic obstructive pulmonary diseases.

To learn more about this report: https://bit.ly/3JSINpT

In addition, the technological advancements in healthcare, increasing expenditure on R&D, and government initiatives to increase awareness of such diseases drive industry growth.

Oxygenators capture a significant share of the industry, accounting for 35%, and it is predicted to retain their position in the coming future. It is accounting for the growing prevalence of lung diseases in children and increasing awareness of ECMO device applications.

In addition, heat-cooler units are projected to experience extensive growth in the near future, led by the wide usage of such units in transplantation or cardiothoracic surgeries, and the growing prevalence of cardiopulmonary diseases such as cystic fibrosis, and chronic obstructive pulmonary diseases.

Portable ECMO machines are largely popular due to their lightweight, and ease of transportation. These machines are majorly used in operative rooms, healthcare setups, cardiac care units, intensive care units, emergency rooms, and neonatal intensive care units. In addition, these devices are widely used in homecare settings in both emerging economies and developed regions.

ECMO machines utilized for respiratory applications contribute a significant revenue share, accounting for 45%, and it is projected to witness the fastest growth in the coming future. The growing prevalence of the target diseases, rising addiction to smoking and tobacco products, along with excessive alcohol consumption, may cause respiratory failure or chronic diseases, with the massive requirement for early diagnosis and diagnostic imaging proliferating the industry.

Moreover, neonatal contribute highly to the rising demand for respiratory ECMO machines. It is caused by the extensive usage of ECMO machines in numerous disorders such as respiratory distress syndrome, pneumonia, and congenital diaphragmatic hernia.

Veno-arterial category witnesses the significant growth in the industry, accounting for over 5% in the coming years. It is led by the reliability, and effectiveness in gas exchange, due to wide usage of cardiac arrest patients, and providing assistance with algorithmic life support techniques to support blood flow. In addition, the rising usage of the veno-arterial for patients suffering from pulmonary hypertension, and thromboembolism, more specifically in abrupt decompensation cause industry propulsion.

The rising adoption of ECMO therapy is proportional to the growing awareness of patients on the advantages of cardiopulmonary support in the treatment of respiratory and cardiac diseases. The programs aimed at increasing awareness of ECMO machines and their applications in the developing regions of the Middle East and Asia, leading to the growing demand for these devices.

North America captures the largest share of the industry, accounting for 40% in 2021, and it is expected to follow the same trend in the coming future. It is led by the rising incidences of respiratory failures, cardiopulmonary disorders, and increasing ECMO machine adoption in regional hospitals.

Therefore, the rising adoption of extracorporeal membrane oxygenation machines is led by the growing prevalence of respiratory failures and cardiopulmonary diseases.

Read More